Alexion Pharmaceuticals is a biotechnology company specializing in rare diseases, a subsidiary of AstraZeneca, focused on developing treatments for conditions like atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria
Alexion Pharmaceuticals is a biotechnology company specializing in rare diseases, a subsidiary of AstraZeneca, focused on developing treatments for conditions like atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria.
The top three firms on F4's Biotech & Life Sciences investor list.